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• Qualitative Systematic review of SMBP from patient and clinician perspectives 
• SMBP allowed patients to attribute changes in their BP to lifestyle changes  
• SMBP empowered patients and facilitated discussion with clinicians  
• Areas of uncertainty would benefit from clarification in guidelines 





















To systematically review the qualitative evidence for patient and clinician perspectives on self-
measurement of blood pressure (SMBP) in the management of hypertension focussing on: how SMBP 
was discussed in consultations; the motivation for patients to start self-monitoring; how both patients 
and clinicians used SMBP to promote behaviour change; perceived barriers and facilitators to SMBP 
use by patients and clinicians.   
Methods 
Medline, Embase, PsycINFO, Cinahl, Web of Science, SocAbs were searched for empirical qualitative 
studies that met the review objectives.  Reporting of included studies was assessed using the COREQ 
framework.  All relevant data from results/findings sections of included reports were extracted, coded 
inductively using thematic analysis, and overarching themes across studies were abstracted. 
Results 
Twelve studies were included in the synthesis involving 358 patients and 91 clinicians.  Three major 
themes are presented: interpretation, attribution and action; convenience and reassurance v anxiety 
and uncertainty; and patient autonomy and empowerment improve patient-clinician alliance. 
Conclusions  
SMBP was successful facilitating the interaction in consultations about hypertension, bridging a 
potential gap in the traditional patient-clinician relationship.  
Practice implications 
Uncertainty could be reduced by providing information specifically about how to interpret SMBP, what 
variation is acceptable, adjustment for home-clinic difference, and for patients what they should be 
concerned about and how to act. 
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1. Introduction 
Evidence from randomised controlled trials (RCTs) shows that self-monitoring blood pressure (SMBP), 
either alone or as part of a complex intervention, is effective in achieving blood pressure (BP) 
reduction and better BP control in patients with hypertension [1-3].  In trials patients who self-monitor 
compared to usual care, on average have lower BP at 6 months (-3.9mmHg systolic [p<0.001], -
2.4mmHg diastolic [p<0.001]), and this effect is increased when SMBP is used with additional support 
such as provision of educational materials, electronic transmission of BP data, telecounseling, etc. [3].  
While SMBP has been shown to be effective at improving BP over periods of 6-18 months, there is 
currently little information as to whether it has any impact on longer-term outcomes such as 
cardiovascular outcomes or death, although modelling the impact of the blood pressure effects is 
likely to be cost effective intervention in the longer term [4].   
For SMBP to achieve an effect on BP, it is likely that regular monitoring initiates or supports behaviour 
change in patients, the healthcare professionals managing their condition, or both.  Potential 
mechanisms through which SMBP may be successful include improvements in medication adherence 
and lifestyle factors in patients, and helping overcome clinical inertia in clinicians[5]. Evidence from 
RCTs shows an association between SMBP use and medication adherence, however the evidence for 
lifestyle change remains equivocal[6].  
Recent clinical guidelines have included recommendations for the use of SMBP in the diagnosis of 
hypertension and in monitoring BP control (i.e. UK NICE 2011, ESH/ESC Europe 2013).  However it is 
unclear to what extent the patient and clinician voice, particularly with regard to acceptability and use 
in “real-world settings” have been incorporated.  When evaluating health technologies, data on 
effectiveness and cost-effectiveness are often prioritised and as such, reviews demonstrating the 
efficacy of SMBP have often ignored the needs, views and perceptions of patients and physicians.  
With a current focus in healthcare on patient-centred care, trials now often include a qualitative 
component to elicit the views and preferences of patients, and sometimes clinicians.  However 
systematic reviews regularly do not include these data, leading to a loss of the patient and physician 
voice, and along with it the context within which interventions may or may not work.  Methods for 
synthesising qualitative evidence and incorporating qualitative evidence in broader reviews have been 
developed, and are becoming more commonplace [7, 8].  This review complements recent reviews of 
the effectiveness of SMBP, by also presenting a synthesis of the available evidence on patient and 
clinician beliefs and preferences. Evidence is drawn from daily practice (i.e. ‘real-world’) settings, or 
linked to involvement in trials or intervention/program development.   
Exploring what works and what is acceptable to both patients and professionals is crucial to optimising 
SMBP interventions for use in real-world settings.  The objectives of this review were to investigate: 
the motivation for patients to start self-monitoring; how patients and clinicians use SMBP to promote 
behaviour change; the perceived barriers and facilitators to SMBP use by patients and clinicians; as 
well as communication and interaction between the two parties. 
 
2. Methods 
The methods are described in detail in the protocol that was developed and registered on the 
PROSPERO database.[9] The ENTREQ (enhancing transparency in reporting the synthesis of qualitative 
research) framework was used to report the results of the review, and includes items grouped into 
five domains: introduction and methodology, literature search and selection, appraisal, and synthesis 
of findings (Appendix 1).[10]  
2.1 Information sources and study selection 
Electronic databases (Medline, Embase, PsycINFO, Cinahl, Web of Science, SocAbs) were searched 
from inception to July 2014 to identify qualitative studies that examined the perspectives of patients 
with hypertension, or the healthcare professionals managing their care, on the use of SMBP.  The 
search strategy was developed in Medline and translated for use in the other databases (Appendix 2).  
Forward and backward citation searches were carried out on any studies included following the 
electronic database searches. 
Studies were eligible if they: 
• included ambulatory patients with hypertension or the healthcare professionals managing 
their care 
• were based in primary care, outpatient clinics or the community 
• Investigated perspectives of self-monitoring of blood pressure 
• reported the results of primary qualitative research (i.e. interviews, focus groups, 
ethnography) 
Two reviewers independently screened the reports for inclusion looking first at title and abstracts (BF, 
JHB).  Full text articles were obtained for studies that appeared to meet the inclusion criteria, or 
studies where a definite decision could not be made. 
2.2 Quality assessment  
Two Reviewers independently assessed each included report using the Consolidated Criteria for 
Reporting Qualitative Health Research (COREQ) framework (BF/NB), which has criteria relating to: 
research team and reflexivity; study design; and analysis and findings.[11]  
 
 
2.3 Data extraction 
Data extraction was first carried out using an adaptation of the JBI QARI form for interpretive research 
(Joanna Briggs Institute qualitative assessment and review instrument).[12] The form allowed broad 
themes to be identified from the studies, which were used to guide the first stage of analysis. 
All text was extracted from sections labelled as ‘results’ or ‘findings’ in the included reports and 
entered into QSR NVivo 10 software for qualitative thematic analysis.          
2.4 Synthesis 
Systematic reviews of qualitative data should go further than simply describing the identified research 
to translating the findings into new theories to answer the research question.  It has been argued that 
three criteria are the foundation of good qualitative reviews:  interpretation of subjective meaning; 
description of social context; and attention to lay knowledge [13].  This review is consistent with these 
methodological aims.   
Thematic synthesis was chosen as it uses methods that are established for the analysis of primary 
data, and translates them for use in systematic reviews.[14] Line-by-line coding was carried out on 
relevant data by one researcher (BF) and agreed throughout by discussion with a second (LH).  Initial 
descriptive codes were grouped into related areas to construct descriptive themes.  Abstracted 
analytical themes were then developed by BF and refined in collaboration with LH and RM.  Coding 
was inductive, with theme development directed by the content of the data.  Wherever possible 
quotes from the participants of included studies (primary data) have been presented to demonstrate 
the analytical themes; where participant quotes were not available author interpretations have been 
included.  Quotes are presented followed by information about the individual (i.e. patient, clinician, 
author interpretation), and setting (i.e. study in ‘daily practice’ setting, linked to a trial, or part of 
intervention development).   
3. Results 
3.1 Searches 
Database searches yielded 668 articles, with two additional records from citation searches. Following 
removal of duplicates and title and abstract screening, 45 full text articles were assessed and 12 
articles met the selection criteria [15-26]. (PRISMA diagram, Figure 1) 
3.2 Study characteristics 
The characteristics of included studies are presented in Table 1.  Some studies included more than one 
population and/or more than one methodology. 
Eleven studies involved patients (n=358), and five involved healthcare professionals (n=91).  The 
earliest article was published in 2003 with the majority (8/12) published during the last five years.  
Seven studies took place in the UK, two in USA, and one each in Malaysia, Canada, and Sweden.  Eight 
studies used interviews and five used focus groups. 
Five studies were qualitative studies embedded within RCTs testing SMBP interventions; three were 
part of SMBP intervention/programme development; and the remaining four investigated SMBP use 
in “daily practice” settings.     
3.3 Quality assessment 
The comprehensiveness of reporting across studies is presented in Table 2.  Reporting varied, with 
studies reporting between 13-25 of the 32 items in the COREQ checklist. The domain including 
research team and reflexivity was not generally well reported, with no item reported by more than 
half of the studies.  The experience and training of the interviewer/facilitator, and their characteristics 
with regard to bias, assumptions and interest in the research topic were only reported by one study 
each.  
The second domain regarding study design was better reported with the exception of: the presence 
of non-participants (1 study); the presence of repeat interviews (0 studies); and the return of 
transcripts to participants for comment/correction (1 study).  The methodological orientation 
underpinning the study was only reported in 2 studies.   
The final domain, analysis and findings, was generally well reported, with the exception of: the 
description of the coding tree (3 studies), participants providing feedback on finding (1 study), and the 
use of software for analysis (5 studies). 
3.4 Thematic synthesis 
Initial coding produced 65 descriptive codes which were grouped into three broad analytical themes.  
The first is pragmatic and describes how patients and clinicians use SMBP, how they interpret the 
results, to what patients attribute high/low/change in BP, and what actions are taken based on SMBP.  
The second theme describes the balance between SMBP being perceived as convenient and reassuring 
contrasted with the potential for causing anxiety and uncertainty.  The final theme deals with patient 
empowerment, autonomy and self-efficacy, and how SMBP changes the traditional patient-clinician 
dynamic.   
3.4.1 Theme 1 - Interpretation, attribution and action 
How patients interpreted their BP and acted upon self-measurement depended to a large extent on 
their understanding of high BP.  While patients were aware of some of the potential risks factors for, 
and consequences of high BP, many did not know what their target BP should be.   
“…people need to know [target BP] because you do get very uncomfortable whether… is this 
the danger level?” Rickerby (2003) [patient, daily practice] 
There was a belief among some patients that BP targets should be personalised to take their individual 
circumstances into account.  Clinicians worked to guidelines, which were perceived to be inflexible in 
their definition of normal and target BP: 
“Clearly, participants were trying to find functional ways to define acceptable ranges of BP 
values.  The guideline values were and initial broad framework for judgements, but within this, 
the personalised norm was deployed as a more meaningful rule of thumb, especially for those 
users who had a relatively consistent history of elevated or reduced readings.” Vasileiou (2013) 
[author interpretation, daily practice] 
“The healthcare professionals worked according to national guidelines, but did not use them 
as a tool to set individual goals.  Subsequently, the patients had neither a goal to focus on not 
an understanding of the actual blood pressure value.” Bengtsson (2014) [author 
interpretation, intervention development] 
There was a consensus between clinicians and patients that SMBP provided a more accurate picture 
of BP than casual clinic measurement due to the larger number of measurements, and it was this that 
led some patients to acquire their own monitor. 
“I can’t remember if they… if I was advised to go and buy a home monitoring machine, but I 
decided to do it anyway… I knew that my blood pressure would be checked every time, 
regularly at the surgery but certainly twice a year… but until that I would like more information 
than that.” Hanley (2013) [patient, intervention development] 
However, the improved accuracy of SMBP was tempered by observation of the inherent variation in 
blood pressure.  Patients and clinicians were aware that self-measured blood pressure tended to be 
lower than clinic measures, which led to a dilemma of which measurement was best to use for 
treatment.  Variation between successive SMBP measurements was also noted, again with uncertainty 
as to which readings should be used.       
“I could do it one minute and then five minutes later it would be completely different.” Rickerby 
(2003) [patient, daily practice] 
“It’s put us in a bit of a dilemma I think cos we’re getting their blood pressures and then when 
they are doing them at home, they’re low, it’s difficult isn’t it, to know what to do.” Jones 
(2013) [practice nurse, trial] 
After using SMBP, patients questioned whether the usual practice of casual clinic measurement was 
sufficient to provide accurate information. 
“Why we need the machine in the house?  […] because our visit to the doctor is infrequent.”  
Abdullah (2011) [patient, daily practice] 
Patients often found that high BP had little impact on their daily lives due to the lack of symptoms, 
and that SMBP gave them an insight into their condition by acting as a proxy for symptoms.  SMBP 
enabled patients to begin to make associations between their BP, symptoms and actions in their daily 
lives, and were then able to identify ways to self-manage. 
“I mean I remember taking my blood pressure and it reading very high and I thought gosh I 
feel really great at the moment.” Rickerby (2003) [patient, daily practice] 
“Perhaps because high blood pressure doesn’t have proper symptoms.  Many think…’oh, I’m 
fine’.” Bengtsson (2014) [HCP, intervention development] 
Some clinicians were concerned that patients were not able to interpret SMBP correctly and might 
incorrectly attribute some symptoms to their BP.   
“…and then you’ve got others; ‘Oh, I feel a bit ill today, I’ll better check my BP’ … and I think 
that’s the danger” Hanley (2013) [HCP, trial] 
Patients were able to use SMBP to monitor the effectiveness of their medication and changes to their 
lifestyle.  SMBP had an impact on whether patients were adherent, whether they initiated or 
terminated treatment, and to what extent they tailored treatment.  In the absence of symptoms, 
having SMBP as a symptom proxy helped demonstrate the effectiveness of treatment.  Clinicians 
recognised the benefits of being able to use SMBP in conjunction with clinic measurements to make 
more rapid adjustments to patients’ medication, thus overcoming clinical inertia.   
“I think taking my BP regularly really made me show that I did need to take the medication 
and that was somewhat motivating… it did show that the medication was important.” 
Lambert-Kerzener (2010) [patient, trial] 
As well as monitoring BP in relation to medication use, patients were able to use SMBP to attribute 
lifestyle factors to high BP, and then in many cases act in response.  However, patients were concerned 
that they only received generalised advice about how lifestyle change could help, and would prefer 
the information to be tailored to hypertension in particular as well as more personalised or tailored 
advice. 
“When it’s high, then I know it’s either my diet or I’ve not been exercising.  So when it’s high 
I’ll take my walks.  I’ll do my aerobics and then cut down on meats, go vegetarian.” Abdullah 
(2011) [patient, daily practice] 
“What I did do, and I’ve stuck to it, I’ve cut out salt.  I was overweight a few years ago and I 
cut out butter, so now I don’t have butter and I don’t have salt. I just use general knowledge.”  
Hanley (2013) [patient, trial] 
“Lifestyle advice was received from multiple sources and perceived to be general rather than 
being targeted at the reasons for them individually developing hypertension.” Hanley (2013) 
[author interpretation, trial] 
One article raised the interesting perspective that patients and clinicians may have different 
expectations of treatment for hypertension:    
“…patients who perceive symptoms they believe are due to high blood pressure should not 
expect to feel better from the treatment. Rather, the treatment should merely serve to prevent 
these patients from feeling worse.” Bengtsson (2014) [author interpretation, intervention 
development] 
 
3.4.2 Theme 2 – convenience and reassurance v anxiety and uncertainty 
SMBP was seen to be convenient and easy to use by patients, and the process was in some cases even 
said to be enjoyable.  Patients were more relaxed out of the clinic environment, and liked the ability 
to be able to monitor as and when they wanted.  Patients felt reassured by being able to check 
symptoms that were potentially attributable to elevated BP.  Patients trusted the technology of 
automated BP monitors.   
“And it always comes in handy; you feel a little bit dodgy, you can always take it to see what 
your blood pressure is.” Ovaisi (2011) [patient, trial] 
“I am reassured and I feel quite happy with the fact that I know that my blood pressure is ok.  
I don’t have to think ‘oh God I haven’t been to the doctor in 4 months, I wonder if my BP is 
alright’ I know it is.”  Jones (2012) [patient, trial] 
While clinicians recognised that patients were generally positive about SMBP, they were concerned 
that some might be anxious about the process or results of self-monitoring, potentially becoming 
neurotic.  They also raised concerns about the ability of some patients to be able to manage the 
process of monitoring.   
“I think they get a little bit neurotic about it.  You know, they’re checking it every day.”  Jones 
(2013) [HCP, trial] 
 “… it may not be applicable to patients with poor technical skills or those who were easily 
‘over focused’.” Halifax (2007) [author interpretation, intervention development] 
Some patients did discuss being anxious, and this was usually in relation to what to do when BP was 
high.  While there is scope for patients to become anxious about high BP readings from self-
monitoring, it was recognised that this anxiety can either inhibit or promote action; anxiety is only a 
bad thing if patients feel that they are unable to do anything about it.   
“I would be quite worried if I took it all the time and it was high.  I just think that I’m perfectly 
alright until I go to the surgery in four months’ time.  I don’t worry about it.  I don’t think about 
it.” Bostock (2009) [patient, intervention development] 
Little evidence was presented that showed patients feeling burdened by the process of self-
monitoring (i.e. according to a rigorous protocol), which was a concern of a small number of clinicians. 
Uncertainty for both patients and clinicians stemmed from how to interpret the results of SMBP, in 
particular coping with variability, as well as when and how to act upon the readings.  For patients, the 
main concern was knowing at what point they needed to act. 
“Where should it [BP] be?  That way I’ll know if me or the missus gotta give a call to an 
ambulance to come get me… because I don’t know what it’s supposed to be.  I don’t know if I 
should call.” Schmid (2009) [patient, daily practice] 
It might be expected that providing clinicians with more accurate BP results would help reduce 
treatment uncertainty, but this does not seem to be the case.  Even when clinicians were provided 
with clear protocols for treatment, as in trials where medication was titrated based on SMBP, clinicians 
were still unsure how to manage borderline cases.  In the daily practice settings clinicians were unsure 
how to incorporate SMBP into routine care, which may have been perceived as reticence by patients. 
“The only problem I had with it in a way is these people that were coming up as uncontrolled 
who were one millimetre above the control level.  And I just thought, oh come on, are you really 
going to add in another drug to bring this down?” Hanley (2013) [HCP, trial] 
“GPs were inconsistent in how they used patients’ home readings.  They reported patients 
sometimes brought home readings to consultations but not in an organised way and even 
when GPs asked to see the readings, they did not always incorporate these into decision 
making.”  Jones (2013) [author interpretation, trial] 
 
3.4.3 Theme 3 – patient empowerment, autonomy and self-efficacy, and how SMBP changes the 
traditional patient-clinician dynamic 
Using SMBP increased patients’ involvement in their own care, increased their knowledge about their 
condition, and empowered them to make changes to benefit/improve their BP.  Empowering patients 
also changed the dynamic of the patient-clinician relationship.  Some patients thought that clinicians 
could be protective of BP results from the clinic, perhaps because the clinicians did not think the 
patient could understand.   
“But when we went for a check-up the doctor rarely tells us the actual BP reading.  He did not 
tell us the readings he just said it’s ok.” Abdullah (2011) [patient, daily practice] 
In contrast SMBP was seen to facilitate discussion, creating a clinician-patient alliance with patients 
better able to understand and be involved in making decisions about treatment.  SMBP provided 
clinicians with more concrete information rather than what could be sometimes ambiguous 
symptoms.  Patients also thought that if they were self-monitoring they might be taken more seriously 
by their clinician. 
“It’s certainly given me more meaningful data to speak to the doctor rather than, ‘Well, I think 
my BP has probably gone up’.” Hanley (2013) [patient, trial] 
“I think the doctor will observe you’re being a bit more serious than vaguely talking about this, 
that and the other.” Vasileiou (2013) [patient, daily practice] 
“The knowledge and information (i.e. SMBP measurements) they brought to the visit 
facilitated a bidirectional conversation that supported their self-care as well as assisted their 
physicians” Lambert-Kerzener (2010) [author interpretation, trial] 
Whilst most clinicians were generally supportive of their patients self-monitoring, some patients met 
with apparent disinterest from their clinician when they tried to communicate the results of self-
monitoring, which was disempowering.  The perceived disinterest may have been due to a lack of clear 
guidance for clinicians as to what to do with data from self-monitoring.   
“I went back quite soon after the initial diagnosis just to confirm that everything was okay.  I 
mentioned that I’d purchased this [SMBP], but that was it really.  We didn’t really speak about 
it any more than that.” Vasileiou (2013) [patient, daily practice] 
SMBP combined with an increased knowledge of BP and hypertension resulted in patients 
demonstrating self-efficacy.  Rather than being in a passive role relying on their GP to both measure 
their BP and dictate treatment, patients felt more in control of their own care. 
“Well the strength is that I have better control.  And then that in collaboration with others 
[nurse/physician] becomes a good foundation for judging how to plan the treatment.” 
Bengtsson (2014) [patient, intervention development] 
Both patients and clinicians recognised that there was scope for SMBP to decrease the workload of 
GPs especially in trials where telemonitoring was used, or where medication was titrated based on 
SMBP by pharmacists, nurses or the patients themselves. 
“It’s quite nice to see if you can ship out some of the work to, or give the stuff back to the 
patients to do which if it makes them more involved and helps them understand is ultimately 
better.” Jones (2013) [HCP, trial] 
“…maybe just saving time for more serious things and other people.” Rickerby (2003) [patient, 
daily practice] 
4. Discussion and conclusion 
4.1 Discussion 
This systematic review and thematic synthesis found three overarching themes in the world-wide 
qualitative literature concerning patient and provider perspectives on self-monitoring of 
hypertension: interpretation, attribution and action; convenience and reassurance versus anxiety and 
uncertainty; and patient empowerment, autonomy and self-efficacy, and how SMBP changes the 
traditional patient-clinician dynamic. 
The synthesis covered SMBP use from a broad range of settings, including trials, development of 
interventions and daily practice, as well as from the perspectives of both patients and clinicians.  Only 
four of the studies represented “real-world” settings where patients and clinicians discussed using 
SMBP as part of their usual practice [15, 24-26].  It is possible that the participants of studies linked to 
trials or intervention development would have different perspectives than the wider population.  With 
the growing enthusiasm for SMBP in everyday practice there is a need for further research into the 
use of SMBP in “real-world” settings, particularly why patients may initiate SMBP, and where it fits 
into their everyday lives.  The results complement systematic reviews of the efficacy of SMBP by 
providing information on ease of use and tolerability as well as day-to-day experiences of self-
monitoring.   
Thematic synthesis was chosen as it uses analytical methods from primary qualitative studies, applies 
them to secondary analysis, and allows the clear identification of prominent themes in a 
methodologically transparent fashion.  As with all qualitative research, the analysis was dependent on 
self-awareness of the potential impact of prior knowledge and experience (reflexivity).  The systematic 
review was conducted by a research team with a broad range of clinical, qualitative, methodological 
and health services research experience; and all were involved in the development and interpretation 
of analytical themes.  
Both patients and clinicians reported being uncomfortable with interpretation of SMBP 
measurements, particularly in light of the variability (between home and clinic; reading to reading in 
the short and long-term).  There was agreement that BP targets were not clear, and that guidelines 
currently do not allow enough flexibility for more personalised targets and norms.  While current UK 
guidelines are clear about how to use SMBP in the diagnosis of hypertension (i.e. NICE 2011), guidance 
from the UK and internationally for its use in managing hypertension is less clear, reflecting the 
underlying evidence [3].   
SMBP was described as providing a proxy for symptoms (in the usually symptomless setting of 
hypertension) allowing patients to link activities of daily life with changes in their BP.  Patients were 
aware that certain lifestyle factors such as diet and exercise could affect their BP, and some even used 
SMBP to experiment with some of these factors.  A recent systematic review found that in RCTs, SMBP 
is associated with improved adherence, but the evidence for associated lifestyle change was equivocal 
[6].  Another systematic review of RCTs showed that SMBP was associated with less therapeutic inertia 
(where medication remains unchanged despite elevated BP), however this was not reported as a 
major factor by the clinicians in the current review [5].  
SMBP was described (by both patients and clinicians) as empowering patients, assisting them in 
managing their BP.  Empowered, or ‘activated’ patients have been shown to be less likely to frequently 
attend their healthcare provider for management of their condition, thus potentially reducing burden 
on clinicians as well as costs [27].   This empowerment had an effect on the traditional patient-clinician 
relationship, with SMBP reported as facilitating discussion about hypertension and giving patients 
more understanding.  Clinicians recognised the benefits of patient self-monitoring and self-
management, but described concern that some patients may become anxious (or even neurotic), 
despite a lack of corroborating patient views.   
SMBP combined with increased knowledge of BP was described as resulting in patients demonstrating 
increased self-efficacy.  This supports the evidence from trials that show that adding educational 
support to SMBP is more effective than SMBP alone [3].  Interestingly educational interventions have 
not been proven to be effective in managing hypertension [28], suggesting that SMBP and education 
may have a synergistic effect.  Future research could further investigate the interaction between 
patient education and SMBP.   
As SMBP appears to influence behaviour change in both patients and clinicians, it is important to 
understand where such an effect is greatest, as this would then provide a logical target for 
optimisation.  Self-monitoring can empower patients and involve them more in their healthcare, as 
well as provide more accurate and timely information for clinicians, but the precise motivations for 
starting it will vary from case to case.  Targeting the interaction between patients and clinicians around 
self-monitoring might therefore be a fruitful avenue for future research. This could include considering 
how SMBP can be used in consultation discussions, particularly in terms of clinician’s acceptance and 
permission giving.  There is evidence that many patients may monitor their BP without informing their 
clinician, and while these patients may have some benefits from self-monitoring in isolation, they 
should be encouraged to bring the information into the clinical encounter [29].  Improved health 
communication has been shown to be associated with better health outcomes in chronic conditions, 
and is therefore a relevant topic for future interventions [30].   
Integrating SMBP into everyday practice remains an issue, with no clear current guidance for clinicians.  
SMBP provides a potential wealth of information, but how it is recorded by patients and then 
communicated to clinicians remains ad hoc.  Telemonitoring is one method that has been shown to 
be successful in trials, however this has yet to be rolled out to scale.[31]   
4.2 Conclusion 
Whilst patients are often aware of the risks of high BP, they can find BP readings and targets confusing.  
SMBP, often in conjunction with education about BP and hypertension, gives patients a better 
understanding of their health state, and a proxy for symptoms in order to be able to act.  SMBP 
empowers patients and facilitates discussion with clinicians.   
Clinicians recognise the benefits of having a more accurate picture of patients’ BP that is provided by 
self-monitoring, but are often concerned about how their patients may react to having to self-monitor.  
More guidance is needed as to how to incorporate self-measured BP into routine practice.   
Further research should focus on the best protocol for SMBP for managing hypertension, as well as 
understanding the role SMBP can play in improving the patient-clinician consultation.  
4.3 Practice implication 
The results of this review suggest that uncertainty for patients and clinicians could be reduced by 
providing information specifically about how to interpret SMBP, what variation is acceptable, how to 
adjust for home-clinic difference, and for patients particularly what they should be concerned about 
and how to act (i.e. when to contact their clinician).  Providing educational materials for patients along 
with self-monitoring may be crucial in optimising the potential health benefits.  Future guidance for 
clinicians should include information on: targets for self-measured BP; how often patients need to 
self-monitor; how the information should be recorded by patients and communicated to clinicians in 
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Table 1 – Characteristics of included studies 




Malaysia Interviews (x6) and 
focus groups (x2) 
Patients with 
hypertension who had 
self-initiated SMBP 
(n=24; 6 interview, 18 
focus group) 
To explore the experiences of purchasing and 
using SMBP at patients’ own initiative 





Sweden Focus groups (x5) Patients with 
hypertension (n=15), 
and healthcare 
professionals (n=12: 4 
nurses, 4 physicians 
and 4 pharmacists) 
To explore and describe relevant aspects of 
hypertension and hypertension treatment, to be 
used in the development of an interactive mobile 
phone self-report system for hypertension self-
management 
Primary healthcare 




Bostock  (2009) 
[17] 
UK  Focus groups (x3) Patients with 
hypertension (n=16), 
and healthcare 
professionals (n=25: 3 
nurses and 6 GPs) 
To establish any concerns patients and clinicians 
may have about mobile phone based BP 
monitoring before planning an RCT. To investigate 
how commonly patients and clinicians  made use 
of home-monitoring results in managing their BP 
Four general practices 






Canada Focus groups (x6) Patients with comorbid 




To determine the information needs of patients 
and clinicians for the design of a telemedicine 
system 
Hypertension clinic, 





UK Interviews (x45) Patients with 
hypertension (n=25), 
and healthcare 
professionals (n=20: 11 
nurses and 9 doctors) 
To explore the experiences of patients and 
professionals taking part in a RCT of remote BP 
telemonitoring supported by primary care. 
To identify factors facilitating or hindering the 
effectiveness of the intervention and those likely 








UK Interviews (x29) Patients with 
hypertension (n=23) 
and family members 
(n=6) 
Qualitative study embedded in RCT to explore 
patients’ views of SMBP with self-titration of anti-
hypertensive medication  





UK Interviews (x16) Healthcare 
professionals (n=16: 13 
GPs, 2 nurses and 1 
healthcare assistant) 
Qualitative study embedded in RCT to explore 
health professionals’ views and experiences of 
patient self-management particularly with respect 







USA Interviews (x146) Patients with 
hypertension (n=146) 
To explore patients’ experiences with a 
multifaceted BP control intervention involving 
interactive voice response technology, home BP 
monitoring and pharmacist led BP management 
Veterans affairs medical 
centre and municipal 




UK Interviews (x26) Patients with 
hypertension who had 
suffered a stroke or TIA 
in past 9 months (n=26) 
From the intervention arm of a community-based 
RCT of SMBP, to explore patients’ experiences of 
self-monitoring with nurse-led support. 
Hospital stroke clinic T 
Rickerby (2003) 
[24] 
UK Interviews (x13) Patients with 
hypertension (n=13) 
To investigate the experiences of individuals who 
had carried out SMBP 
Single GP practice RW 
Schmid (2009) 
[25] 
USA Focus groups (x6) Patients with a stroke 
or TIA in the past 24 
months (n=28) 
To identify BP self-management strategies used 
by individuals who had suffered a stroke or TIA. 






UK Interviews (x18) Patients – users of 
SMBP (n=18) 
To explore the reasoning behind the 
interpretation of home readings, and the way 
people interact with their doctor with reference 
to these values and the practice of SMBP 
Community RW 



















5. Experience and training 
6. Relationship established 
7. Participant know














14. Setting of data collection 
15. Presence of non-participants 






19. Audio/visual recording 
20. Field notes 
21. Duration 
22. Data saturation 
23. Transcripts returned 
24. N
um
ber of data coders 
25. Description of the coding tree 




28. Participant checking 
29. Q
uotations presented 
30. Data and findings consistent 
31. Clarity of m
ajor them
es 
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Bengtsson 
2014 [16] 
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Bostock 
2009 [17] 
N N N Y N N N N N Y N Y N Y N Y N N Y Y Y N N N Y N N N Y Y Y Y 11 
Halifax 
2007 [18] 
N Y N Y N N N N N Y Y Y Y Y Y Y N N Y N Y N N N N Y N N N N Y Y 14 
Hanley 
2013 [19] 
Y N Y Y Y N N Y N Y Y Y Y Y N Y Y N Y N Y Y Y Y Y Y Y Y Y Y Y Y 25 
Jones 
2012 [20] 
N Y Y Y N N N N N Y N Y Y Y N Y N N Y Y Y Y N N N Y N N Y Y Y Y 17 
Jones 
2013 [21] 




Y Y N Y N N N N N Y Y Y Y Y N Y N N Y N Y N N Y N Y N N Y Y Y Y 17 
Ovaisi 
2011 [23] 
N Y Y Y N N N N N Y N Y Y Y N Y N N Y Y Y N N Y N Y Y N Y Y Y Y 18 
Rickerby 
2003 [24] 
Y N N Y N N N N Y Y Y Y Y Y N Y Y N Y Y N Y N Y N Y N N Y Y Y Y 19 
Schmid 
2009 [25] 
N Y N Y N N N N N Y Y Y Y Y N Y N N Y N N Y N Y N Y N N Y Y Y Y 16 
Vasileiou 
2013 [26] 
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n Additional records identified 
through citation searches 
(n = 2) 
Records after duplicates removed 
(n = 405) 
Title and abstracts 
screened 
(n = 405) 
Records excluded 
(n = 360) 
Full-text articles assessed 
for eligibility 
(n = 45) 
Full-text articles excluded, 
with reasons 
(n =33: 
n=3 perspective (not 
hypertensive adults or 
HCPs) 
n=18 intervention (no 
discussion of SMBP) 
   
   
    
Studies included in 
thematic synthesis 
(n = 12) 
